Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Status:
Completed
Trial end date:
2017-01-03
Target enrollment:
Participant gender:
Summary
Purpose of this study is to determine the effectiveness of the drug combination carboplatin,
paclitaxel, and bevacizumab(Avastin) in patients with advanced stage endometrial carcinoma.